v3.26.1
Business Combinations - Summary of Fair Values of Identifiable Net Assets (Details)
€ in Millions
Dec. 31, 2025
EUR (€)
Dec. 03, 2025
Jan. 31, 2025
EUR (€)
Liabilities      
Goodwill from the acquisition     € (6.9)
Biotheus Inc.,      
Assets      
Intangible assets     172.8
Property, plant and equipment and right-of-use assets     70.7
Cash and cash equivalents     122.4
Other assets non-current and current     20.6
Total assets     386.5
Liabilities      
Non-current liabilities     36.3
Current liabilities     55.1
Total liabilities     91.4
Total identifiable net assets at fair value     295.1
Bargain from the acquisition     (15.0)
Consideration      
Fair value of shares transferred     847.4
Cash paid (fractional shares)     767.8
Contingent consideration (milestones)     79.6
Effects in connection with pre-existing relationships     (567.3)
Total consideration     € 280.1
CureVac      
Assets      
Intangible assets € 240.3    
Property, plant and equipment and right-of-use assets 116.3    
Cash and cash equivalents 264.5    
Other assets non-current and current 26.3    
Total assets 647.4    
Liabilities      
Non-current liabilities 43.5    
Current liabilities 213.6    
Total liabilities 257.1    
Total identifiable net assets at fair value 390.3    
Goodwill from the acquisition 10.6    
Consideration      
Fair value of shares transferred 1,001.1    
thereof fair value of shares from first and second offer period transferred 868.4    
thereof fair value of shares for the back-end measures 132.7    
Cash paid (fractional shares) 0.1    
Effects in connection with pre-existing relationships (600.3)    
Total consideration € 400.9    
Shares issued (in shares) 12,075,629 184,071,410